No difference in RR was observed in patients with R-sided colon cancer according to treatment (RR 11% in patients treated with anti-EGFR vs RR 10% in patients treated with R/T, p=0.99) (Figure 3). This evidence concerns the gene EGFR and colonic neoplasm.